Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Neumora Therapeutics, Inc. (NMRA)

0.5033 +0.0163 (+3.35%)
At close: November 6 at 4:00:00 PM EST
0.5200 +0.0167 (+3.32%)
After hours: November 6 at 6:12:45 PM EST
Trade NMRA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0 0 0 0 0
Selling, General and Administrative Expenses
-53,163 -60,091 -62,537 -45,475 -31,121
Research and Development Expenses
-158,071 -181,065 -200,927 -206,623 -104,749
Operating Income/Expenses
-211,234 -241,156 -263,464 -252,098 -135,870
Total Operating Profit/Loss
-211,234 -241,156 -263,464 -252,098 -135,870
Total Net Finance Income/Expense
-1,271 5,125 19,933 16,611 4,561
Other Income/Expense, Non-Operating
-210 -767 -78 -170 405
Non-Operating Income/Expenses, Total
-1,481 4,358 19,855 16,441 4,966
Pretax Income
-212,715 -236,798 -243,609 -235,657 -130,904
Provision for Income Tax
-30 -130 -178 -268 0
Net Income from Continuing Operations
-212,745 -236,928 -243,787 -235,925 -130,904
Net Income after Extraordinary Items and Discontinued Operations
-212,745 -236,928 -243,787 -235,925 -130,904
Net Income after Non-Controlling/Minority Interests
-212,745 -236,928 -243,787 -235,925 -130,904
Net Income Available to Common Stockholders
-212,745 -236,928 -243,787 -235,925 -130,904
Diluted Net Income Available to Common Stockholders
-212,745 -236,928 -243,787 -235,925 -130,904
Basic EPS
-1.23 -1.45 -1.53 -3.63 -4.88
Diluted EPS
-1.23 -1.45 -1.53 -3.63 -4.88
Basic Weighted Average Shares Outstanding
173,857 163,391 159,377 65,021 26,841
Diluted Weighted Average Shares Outstanding
173,857 163,391 159,377 65,021 26,841
Income Statement, Supplemental
EBIT
-211,444 -241,923 -263,542 -252,268 -135,465
EBITDA
-211,397 -241,715 -262,911 -251,600 -134,871
Normalized EBITDA
-183,421 -211,197 -222,921 -234,360 -127,132
Normalized Income
-190,643.9600 -212,818.7800 -212,194.9000 -222,305.4000 -123,165
Total Unusual Items
27,976 30,518 39,990 17,240 7,739
Total Unusual Items Excluding Goodwill
27,976 30,518 39,990 17,240 7,739
Tax Effect of Unusual Items
5,874.9600 6,408.7800 8,397.9000 3,620.4000 0
Tax Rate, Calculated
0.21 0.21 0.21 0.21 0.00
12/31/2022 - 9/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: